[LLIBRE][B] RNA, the epicenter of genetic information

J Mattick, P Amaral - 2023 - library.oapen.org
The origin story and emergence of molecular biology is muddled. The early triumphs in
bacterial genetics and the complexity of animal and plant genomes complicate an intricate …

RNA binding proteins in MLL-rearranged leukemia

TM Tran, DS Rao - Experimental Hematology & Oncology, 2022 - Springer
RNA binding proteins (RBPs) have recently emerged as important post-transcriptional gene
expression regulators in both normal development and disease. RBPs influence the fate of …

Targeting miR-126 in inv (16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance

L Zhang, LXT Nguyen, YC Chen, D Wu… - Nature …, 2021 - nature.com
Acute myeloid leukemia (AML) harboring inv (16)(p13q22) expresses high levels of miR-
126. Here we show that the CBFB-MYH11 (CM) fusion gene upregulates miR-126 …

MicroRNA networks in FLT3-ITD acute myeloid leukemia

DH Hoang, D Zhao, S Branciamore, D Maestrini… - Proceedings of the …, 2022 - pnas.org
MiR-126 and miR-155 are key microRNAs (miRNAs) that regulate, respectively,
hematopoietic cell quiescence and proliferation. Herein we showed that in acute myeloid …

circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis

W Wei, J Pan, J Wang, S Mao, Y Qian… - Molecular …, 2023 - Wiley Online Library
Circular RNAs (circRNAs), a type of endogenous noncoding RNA (ncRNA), exert vital roles
in leukemia progression and are promising prognostic factors. Here, we report a novel …

[HTML][HTML] Splice and dice: intronic microRNAs, splicing and cancer

ACH Wong, JEJ Rasko - Biomedicines, 2021 - mdpi.com
Introns span only a quarter of the human genome, yet they host around 60% of all known
microRNAs. Emerging evidence indicates the adaptive advantage of microRNAs residing …

Spred1 deficit promotes treatment resistance and transformation of chronic phase CML

J Qiao, C Liang, D Zhao, LXT Nguyen, F Chen, S Suo… - Leukemia, 2022 - nature.com
Spred1 is highly expressed in normal hematopoietic stem cells (HSCs). Lack of Spred1
function has been associated with aberrant hematopoiesis and acute leukemias. In chronic …

Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia

BJ Ball, PB Koller, V Pullarkat - Current Opinion in Oncology, 2022 - journals.lww.com
The development of venetoclax with HMA has transformed care for elderly adults with AML
and opened the door for novel combinations of venetoclax with other nucleoside analogs …

[PDF][PDF] miRNA-126 as a Biomarker for Cancer Stem Cells: Role in Chemotherapy Resistance in Iraqi Patients with Acute Myeloid Leukemia

NS Al-Maliki, ZK Zedan - Al-Rafidain Journal of Medical Sciences (ISSN …, 2024 - iasj.net
Background: Acute myeloid leukemia (AML) is characterized as an aggressive blood cancer
with rapid growth of immature leukemic cells. It appears that each subtype of AML displays a …

BMPMDA: prediction of MiRNA-disease associations using a space projection model based on block matrix

Y Shen, JX Liu, MM Yin, CH Zheng, YL Gao - … Sciences: Computational Life …, 2023 - Springer
With the high-quality development of bioinformatics technology, miRNA-disease
associations (MDAs) are gradually being uncovered. At present, convenient and efficient …